News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Phase 2 results from the NeoCOAST-2 study demonstrated that the combination of durvalumab with Dato-DXd…
New data from landmark analysis presented today report a decreased risk of disease recurrence or…
New data presented today reveals that the PanCan nodule management protocol demonstrates superior performance in…
The evolution of retinoblastoma treatment over the past 15 years has resulted in a higher…
UICC’s flagship event is taking place 17-19 September in Geneva, Switzerland. It is expected to…
Treatment of gastrointestinal (GI) cancers is catching up with other areas of oncology and offering…
Welcome to Episode 6 of the second series of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson for the first ASCO 2024 Special.
The 14-month median follow-up data from the pivotal Phase 1/2 LINKER-MM1 trial of linvoseltamab in…
Combination of alpha- and beta-radionuclide therapy is feasible, tolerable, and effective for colorectal cancer, according…
Welcome to Episode 6 of the second series of The Oncology Journal Club! Our Host Craig Underhill is joined by Dr Kate Clarke and Professor Christopher Jackson for the first ASCO 2024 Special.